> Skip repeated content

Mary Kirkland Center for Lupus Care

Mary Kirkland Center for Lupus Care 2009-2010 PubMed Publications

1: Lockshin MD. Transition. Arthritis Rheum. 2010 Jun;62(6):1564. PubMed PMID:20506245.

2: Perna M, Roman MJ, Alpert DR, Crow MK, Lockshin MD, Sammaritano L, Devereux RB, Cooke JP, Salmon JE. Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. Arthritis Rheum. 2010 Jun;62(6):1718-22. PubMed PMID: 20155836.

3: Erkan D, Kozora E, Lockshin MD. Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiology. 2010 May 14. [Epub ahead of print] PubMed PMID: 20472406.

4: Izmirly PM, Kim MY, Llanos C, Le PU, Guerra MM, Askanase AD, Salmon JE, Buyon JP. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis. 2010 May 6. [Epub ahead of print] PubMed PMID: 20447951.

5: Lynch AM, Salmon JE. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta. 2010 Apr 26. [Epub ahead of print] PubMed PMID: 20427084.

6: Lockshin MD. Non-hormonal explanations for sex discrepancy in human illness. Ann N Y Acad Sci. 2010 Apr;1193(1):22-4. Review. PubMed PMID: 20398003.

7: Gelber SE, Salmon JE. Autoimmunity: effectiveness of treatments for pregnant women with APS. Nat Rev Rheumatol. 2010 Apr;6(4):187-9. PubMed PMID: 20357787.

8: Alpert DR, Salmon JE. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: a rebuttal. J Thromb Haemost. 2010 Mar 23. [Epub ahead of print] PubMed PMID: 20345710.

9: Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N, Alaedini A. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun. 2010 Mar 18. [Epub ahead of print] PubMed PMID: 20227484.

10: Lynch AM, Murphy JR, Gibbs RS, Levine RJ, Giclas PC, Salmon JE, Holers VM. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG. 2010 Mar;117(4):456-62. Epub 2010 Jan 14. PubMed PMID: 20074261.

11: Erkan D. Risk quantification in antiphospholipid syndrome. Women's Health (Lond Engl). 2010 Mar;6(2):179-82. PubMed PMID: 20187724.

12: Lockshin MD, Katz PP, Yelin EH. Clinical trial registration and publication of randomized controlled trials. JAMA. 2010 Feb 10;303(6):517-8; author reply 518. PubMed PMID: 20145227.

13: Mavragani CP, La DT, Stohl W, Crow MK. Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort. Arthritis Rheum. 2010 Feb;62(2):392-401. PubMed PMID: 20112385; PubMed Central PMCID: PMC2821991.

14: Crow MK. Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease. Autoimmunity. 2010 Feb;43(1):7-16. Review. PubMed PMID: 19961365.

15: Crow MK. Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am. 2010 Feb;36(1):173-86, x. PubMed PMID: 20202598; PubMed Central PMCID: PMC2843146.

16: Markenson JA. Rheumatic manifestations of endocrine diseases. Curr Opin Rheumatol. 2010 Jan;22(1):64-71. Review. PubMed PMID: 19935068.

17: Pierangeli SS, Erkan D. Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet? Lupus. 2010;19(4):475-85. PubMed PMID: 20353991.

18: Erkan D, Lockshin MD. Non-criteria manifestations of antiphospholipid syndrome. Lupus. 2010;19(4):424-7. PubMed PMID: 20353981.

19: Cervera R; CAPS Registry Project Group (Erkan D, Lockshin MD). Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'. Lupus. 2010;19(4):412-8. PubMed PMID: 20353979.

20: Erkan D, Barbhaiya M, George D, Sammaritano L, Lockshin MD. Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-{beta}2-glycoprotein-I antibody positivity offer additional predictive information? Lupus. 2010;19(5):613-9. Epub 2009 Nov 24. PubMed PMID: 19934177.

21: Berman JR, Lazaro D, Fields T, Bass AR, Weinstein E, Putterman C, Dwyer E, Krasnokutsky S, Paget SA, Pillinger MH. The New York City Rheumatology Objective Structured Clinical Examination: five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change. Arthritis Rheum. 2009 Dec 15;61(12):1686-93. PubMed PMID: 19950304.

22: Katz PP, Yelin EH, Lockshin MD. The child, grown, becomes independent. Arthritis Rheum. 2009 Dec;60(12):3523. PubMed PMID: 19950273.

23: Koolaee RM, Singer O, Bass A, Winchester R, Seshan S, Erkan D. Hepatitis C-and Human Immunodeficiency Virus-Induced Hypersensitivity Vasculitis : A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS J. 2009 Nov 17. [Epub ahead of print] PubMed PMID: 19921341.

24: Gordon JK, Magro C, Lu T, Schneider R, Chiu A, Furman RR, Solomon G, Bass A, Erkan D. Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease : A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery. HSS J. 2009 Sep;5(2):169-77. Epub 2009 Jul 16. PubMed PMID: 19609622; PubMed Central PMCID: PMC2744761.

25: George D, Erkan D. Antiphospholipid syndrome. Prog Cardiovasc Dis. 2009 Sep-Oct;52(2):115-25. Review. PubMed PMID: 19732604.

26: Scanzello CR, Umoh E, Pessler F, Diaz-Torne C, Miles T, Dicarlo E, Potter HG, Mandl L, Marx R, Rodeo S, Goldring SR, Crow MK. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage. 2009 Aug;17(8):1040-8. Epub 2009 Mar 6. PubMed PMID: 19289234.

27: Kariuki SN, Moore JG, Kirou KA, Crow MK, Utset TO, Niewold TB. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun. 2009 Jul;10(5):487-94. Epub 2009 Apr 2. PubMed PMID: 19339987; PubMed Central PMCID: PMC2762275.

28: Bucciarelli S, Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse. Clin Rev Allergy Immunol. 2009 Jun;36(2-3):80-4. Review. PubMed PMID: 19051065.

29: Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G, Shoenfeld Y, Ingelmo M, Espinos G; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (Erkan D, Lockshin MD) (European Forum On Antiphospholipid Antibodies). Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". J Autoimmun. 2009 May-Jun;32(3-4):240-5. Epub 2009 Mar 26. PubMed PMID: 19324520.

30: Peerschke EI, Yin W, Alpert DR, Roubey RA, Salmon JE, Ghebrehiwet B. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus. 2009 May;18(6):530-8. PubMed PMID: 19395455; PubMed Central PMCID: PMC2707931.

31: Erkan D, Lockshin MD. New approaches for managing antiphospholipid syndrome. Nat Clin Pract Rheumatol. 2009 Mar;5(3):160-70. Review. PubMed PMID: 19252521.

32: Fernandez DR, Telarico T, Bonilla E, Li Q, Banerjee S, Middleton FA, Phillips PE, Crow MK, Oess S, Muller-Esterl W, Perl A. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol. 2009 Feb 15;182(4):2063-73. PubMed PMID: 19201859; PubMed Central PMCID: PMC2676112.

33: Kim S, Moskowitz NK, Dicarlo EF, Bass AR, Erkan D, Lockshin MD. Catastrophic antiphospholipid syndrome triggered by sepsis. HSS J. 2009 Feb;5(1):67-72. Epub 2008 Dec 19. PubMed PMID: 19096893; PubMed Central PMCID: PMC2642545.

34: Crow MK. Developments in the clinical understanding of lupus. Arthritis Res Ther. 2009;11(5):245. Epub 2009 Oct 14. Review. PubMed PMID: 19849817; PubMed Central PMCID: PMC2787273.

35: Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, Crow MK, Sammaritano L, Levine DM, Salmon JE. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum. 2009 Jan;60(1):22-9. PubMed PMID: 19116901; PubMed Central PMCID: PMC2626148.

36: Kariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, Niewold TB. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol. 2009 Jan 1;182(1):34-8. PubMed PMID: 19109131; PubMed Central PMCID: PMC2716754.

37: Onel KB, Huo D, Hastings D, Fryer-Biggs J, Crow MK, Onel K. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults. Lupus. 2009 Jan;18(1):61-6. PubMed PMID: 19074170; PubMed Central PMCID: PMC2801155.